Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells

Cancer Biomarkers : Section a of Disease Markers
Qiang WangGuowei Shi

Abstract

Krüppel-like factor 13 (KLF13), a member of the KLF family, is involved in the development of immunological diseases and tumor progression. However, the expression patterns and potential functions of KLF13 in prostate carcinoma are still unknown. Here, we aimed to study the roles and mechanisms of KLF13 in prostate cancer. The expression levels of KLF13 was detected by Immunohistochemistry in prostate tumor tissues and the paired non-tumor tissues. The effects of KLF13 up-regulation was tested by performing CCK8, cell colon formation, flow cytometric analysis and measurement of tumor proliferation in nude mice. Signaling pathway was analyzed by Western blot. The current study, for the first time, found that KLF13 was downregulated in prostate tumor tissues as compared to the paired non-tumor tissues. The overexpression of KLF13 dramatically inhibited cell proliferation and induced apoptosis by suppressing the AKT pathway in human prostate cancer cells. Moreover, the ectopic expression of KLF13 efficiently delayed the onset of PC3 xenografts and inhibited the tumor growth in vivo. KLF13 functions as a tumor suppressor protein in PCa, and the pharmacological activation of KLF13 might represent a potential approach for the treatme...Continue Reading

References

Nov 17, 2005·Oncogene·Pradip K Majumder, William R Sellers
Nov 28, 2006·European Urology·Eija H SeppäläJohanna Schleutker
Aug 30, 2008·The Journal of Clinical Investigation·Carolyn Waugh KinkadeCory Abate-Shen
Jun 12, 2010·Cytogenetic and Genome Research·B J Henson, S M Gollin
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Mar 5, 2013·Endocrine-related Cancer·Rhonda L Bitting, Andrew J Armstrong
Sep 26, 2013·Nature Reviews. Cancer·Marie-Pier TetreaultJonathan P Katz
Jun 16, 2015·Lancet·Gerhardt AttardJohann S de Bono
Jun 19, 2015·Cell & Bioscience·Shuzhong JiangSiwen Jiang
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Oct 12, 2017·Journal of Leukocyte Biology·Adam G PeresJoaquín Madrenas

❮ Previous
Next ❯

Citations

Feb 28, 2020·OncoTargets and Therapy·Jun ZhangGuowei Shi
Jun 25, 2020·Molecular Neurobiology·José Ávila-MendozaRobert J Denver
Feb 14, 2021·Drug Discovery Today·Christian Bailly, Gérard Vergoten

❮ Previous
Next ❯

Datasets Mentioned

BETA
KLF13

Methods Mentioned

BETA
PCR
electrophoresis
flow cytometry
transfections
xenograft
xenografts

Software Mentioned

GraphPad Prism
GraphPad

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Wen-Fang LiChang-An Liu
Cancer Biomarkers : Section a of Disease Markers
Shiying ZhangHeqing Guo
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Gang LuoGuosong Jiang
© 2022 Meta ULC. All rights reserved